Visceral fat is linked to higher levels of inflammation and contributes to conditions such as obesity, diabetes, and heart disease
120.00 94 in stock For research use only Not for human or animal use Our Retatrutide 20mg vial is a triple receptor agonist studied for its role in metabolism, appetite regulation, and body weight management
Puberty and depression: the roles of age, pubertal status and pubertal timing
GLP-1 therapies influence pathways tied to addiction and reward, according to the Endocrine Society A randomized clinical trial published in JAMA Psychiatry found semaglutide reduced alcohol cravings and consumption Users commonly report: Reduced desire to drink Feeling full faster when drinking Less reward from alcohol The data: early, but directionally consistent While long-term industry sales data is still developing, the early signals from clinical studies, observational research, and population polling all point in the same direction: GLP-1 use is associated with lower alcohol consumption for at least some users
Theres not enough research to recommend GLP-1s as a treatment for ADHD
